Bangor Savings Bank Reduces Holdings in UiPath Inc. (NYSE:PATH)

Bangor Savings Bank decreased its position in shares of UiPath Inc. (NYSE:PATH - Free Report) by 96.9% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,059 shares of the healthcare company's stock after selling 64,981 shares during the period. Bangor Savings Bank's holdings in UiPath were worth $26,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in PATH. ORG Partners LLC raised its stake in UiPath by 875.6% during the 1st quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company's stock worth $27,000 after acquiring an additional 1,112 shares during the period. Hantz Financial Services Inc. purchased a new stake in UiPath during the 2nd quarter valued at approximately $28,000. Redwood Wealth Management Group LLC purchased a new stake in UiPath during the 2nd quarter valued at approximately $43,000. GAMMA Investing LLC grew its holdings in UiPath by 40.2% during the 1st quarter. GAMMA Investing LLC now owns 2,204 shares of the healthcare company's stock valued at $50,000 after buying an additional 632 shares in the last quarter. Finally, Benjamin F. Edwards & Company Inc. grew its holdings in UiPath by 122.5% during the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 2,556 shares of the healthcare company's stock valued at $58,000 after buying an additional 1,407 shares in the last quarter. Institutional investors own 62.50% of the company's stock.

Analyst Ratings Changes

A number of brokerages have issued reports on PATH. Barclays increased their price objective on shares of UiPath from $14.00 to $15.00 and gave the company an "equal weight" rating in a report on Friday, September 6th. Evercore ISI raised their target price on shares of UiPath from $13.00 to $16.00 and gave the company an "in-line" rating in a report on Friday, September 6th. TD Cowen cut their target price on shares of UiPath from $17.00 to $16.00 and set a "hold" rating for the company in a report on Friday, September 6th. BMO Capital Markets raised their target price on shares of UiPath from $14.00 to $15.00 and gave the company a "market perform" rating in a report on Friday, September 6th. Finally, Bank of America raised their target price on shares of UiPath from $16.00 to $18.00 and gave the company a "neutral" rating in a report on Friday, September 6th. Sixteen investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $17.71.

UiPath Price Performance

Shares of NYSE:PATH traded up $0.27 on Wednesday, hitting $12.44. 6,704,042 shares of the company's stock were exchanged, compared to its average volume of 9,923,436. UiPath Inc. has a 12 month low of $10.37 and a 12 month high of $27.87. The stock has a market capitalization of $7.13 billion, a price-to-earnings ratio of -77.44 and a beta of 0.88. The business's 50 day simple moving average is $12.18 and its two-hundred day simple moving average is $14.90.

UiPath (NYSE:PATH - Get Free Report) last released its earnings results on Thursday, September 5th. The healthcare company reported $0.04 earnings per share for the quarter, topping the consensus estimate of $0.03 by $0.01. UiPath had a negative return on equity of 3.98% and a negative net margin of 8.13%. The business had revenue of $316.00 million during the quarter, compared to the consensus estimate of $303.69 million. During the same period last year, the company earned ($0.09) earnings per share. The business's revenue for the quarter was up 10.0% compared to the same quarter last year. Equities analysts forecast that UiPath Inc. will post -0.23 EPS for the current fiscal year.

Insider Activity at UiPath

In related news, CFO Ashim Gupta sold 47,671 shares of UiPath stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $12.07, for a total value of $575,388.97. Following the completion of the sale, the chief financial officer now directly owns 849,917 shares in the company, valued at $10,258,498.19. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 22.37% of the stock is currently owned by corporate insiders.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.